We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$13.9M
(-12%)
Cap. Flow
+$1.12M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
39.11%
Holding
102
New
5
Increased
6
Reduced
39
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Usio Inc
USIO
|
+$1.23M |
| 2 |
EMKR
Emcore Corp
EMKR
|
+$975K |
| 3 |
RGF
The Real Good Food Company, Inc. Class A Common Stock
RGF
|
+$604K |
| 4 |
Creative Realities
CREX
|
+$252K |
| 5 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
+$189K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PFIE
Profire Energy, Inc
PFIE
|
+$901K |
| 2 |
AUGX
Augmedix, Inc. Common Stock
AUGX
|
+$703K |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$84.8K |
| 4 |
Option Care Health
OPCH
|
+$67.4K |
| 5 |
ePlus
PLUS
|
+$61.7K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.28% |
| 2 | Technology | 24.79% |
| 3 | Industrials | 9.97% |
| 4 | Communication Services | 6.27% |
| 5 | Consumer Staples | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
AtriCure
ATRC
$1.98B
| $1.29M | 1.27% |
29,350
-1,000
| -3% | -$48.8K |
|
27
General Mills
GIS
$19.3B
| $1.27M | 1.26% |
19,825
| – | – |
|
28
Merck
MRK
$316B
| $1.22M | 1.21% |
11,825
| – | – |
|
29
Tactile Systems Technology
TCMD
$680M
| $1.17M | 1.16% |
83,300
-50
| -0.1% | -$979 |
|
30
MDxHealth
MDXH
$22.7M
| $1.13M | 1.12% |
404,225
+1,000
| +0.2% | +$3.33K |
|
|
EMKR
31
DELISTED
Emcore Corp
EMKR
| $1.11M | 1.1% |
232,600
+150,000
| +182% | +$975K |
|
32
Vericel Corp
VCEL
$2.37B
| $1.07M | 1.06% |
32,000
-867
| -3% | -$30.1K |
|
33
Gilead Sciences
GILD
$168B
| $1.02M | 1.01% |
13,583
-34
| -0.2% | -$2.62K |
|
34
Magnite
MGNI
$2.99B
| $1M | 1% |
133,325
| – | – |
|
|
PDCO
35
DELISTED
Patterson Companies, Inc.
PDCO
| $992K | 0.98% |
33,470
| – | – |
|
36
Bristol-Myers Squibb
BMY
$135B
| $908K | 0.9% |
15,641
| – | – |
|
37
Target
TGT
$67.3B
| $827K | 0.82% |
7,475
| – | – |
|
|
SKYT
38
DELISTED
SkyWater Technology
SKYT
| $822K | 0.81% |
136,500
| – | – |
|
39
Ciena
CIEN
$58.2B
| $815K | 0.81% |
17,250
| – | – |
|
40
Apple
AAPL
$4.52T
| $796K | 0.79% |
4,650
| – | – |
|
41
OptimizeRx
OPRX
$129M
| $792K | 0.79% |
101,863
| – | – |
|
42
Baxter International
BAX
$14.7B
| $790K | 0.78% |
20,934
| – | – |
|
43
Intel
INTC
$509B
| $766K | 0.76% |
21,550
| – | – |
|
44
Perspective Therapeutics
CATX
$342M
| $731K | 0.72% |
267,164
-300
| -0.1% | -$1.4K |
|
45
Apyx Medical
APYX
$180M
| $678K | 0.67% |
211,800
-4,200
| -2% | -$19.6K |
|
46
Exagen
XGN
$156M
| $639K | 0.63% |
263,905
| – | – |
|
47
Journey Medical
DERM
$176M
| $615K | 0.61% |
224,295
-2,100
| -0.9% | -$4.69K |
|
|
48
ePlus
PLUS
$2.54B
| $603K | 0.6% |
9,500
-1,000
| -10% | -$61.7K |
|
49
Donaldson
DCI
$11.4B
| $589K | 0.58% |
9,884
| – | – |
|
50
Backblaze
BLZE
$1.19B
| $585K | 0.58% |
106,335
| – | – |
|
Similar funds
PWP
BF
SFG
HWMG
FTEA
WT
BAM
WLG
Perkins Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Perkins Capital Management held 102 positions worth $101M, down 12% from $115M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management's Q3 2023 filing shows 5 new, 6 increased, 39 reduced and 4 closed positions. Its largest new stake was The Real Good Food Company, Inc. Class A Common Stock: 12,333 shares worth $496K. The largest sale was Profire Energy, Inc, an estimated $901K.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 55% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q3 2023 buy was The Real Good Food Company, Inc. Class A Common Stock: 12,333 shares worth $496K.
- Perkins Capital Management added most to Usio Inc in Q3 2023, an estimated $1.23M increase.
- Perkins Capital Management's biggest Q3 2023 reduction was Profire Energy, Inc, cutting an estimated $901K.
- Perkins Capital Management fully exited Paratek Pharmaceuticals, Inc. in Q3 2023, selling an estimated $30K.
- Perkins Capital Management's ten largest holdings make up 39% of its $101M portfolio in Q3 2023.
- Perkins Capital Management opened 5 new positions and closed 4 in Q3 2023.
- Perkins Capital Management's portfolio value fell 12% quarter-over-quarter to $101M.
Based on Perkins Capital Management's 13F filing for Q3 2023, filed 2 Nov 2023.